MetaCap

STERIS (Ireland) Financial Ratios

NYSE: STEHealth CareIndustrial SpecialtiesUSD

214.40+3.64 (+1.73%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

STERIS (Ireland) ratio analysis

STERIS (Ireland) earned a net margin of 13.2% in FY 2026, up from 11.3% a year earlier. Gross margin was 44.2% compared with a median of 43.2% over the prior 9 years. Return on equity reached 10.9%, meaning STERIS (Ireland) generated 0.11 dollars of profit for every dollar of shareholders' equity.

Debt-to-equity stood at 0.27 versus 0.31 the year before, and the current ratio was 2.09. At the end of FY 2026, STE traded at 27.6 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 27.5 to 178.8, with a median of 38.9. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

STERIS (Ireland) financial ratios (annual)

STERIS (Ireland) annual financial ratios
RatioFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
P/E ratio (at fiscal year end)27.5834.2959.01178.77100.0041.7929.1436.0627.5454.27
Price / sales3.623.844.324.205.735.313.883.893.032.27
Price / book2.993.173.523.143.704.253.453.412.482.11
Gross margin44.2%44.0%43.2%43.7%44.6%43.2%43.6%42.2%41.7%39.3%
Operating margin18.6%15.9%16.3%17.4%11.3%17.6%17.7%14.8%15.3%8.7%
Net margin13.2%11.3%7.4%2.4%5.8%12.8%13.5%10.9%11.1%4.2%
Free cash flow margin16.4%14.3%11.9%8.7%9.4%14.5%12.4%12.6%11.2%9.6%
Return on equity (ROE)10.9%9.3%6.0%1.8%3.7%10.2%12.0%9.6%9.1%3.9%
Return on assets (ROA)7.3%6.1%3.4%1.0%2.1%6.0%7.5%6.0%5.6%—
Debt / equity0.270.310.510.510.470.430.340.370.41—
Current ratio2.091.963.082.332.042.102.432.272.48—
Revenue growth8.7%6.2%13.3%7.4%35.9%2.5%8.9%6.2%0.3%—
EPS growth27.9%62.7%256.1%-56.9%-46.4%-2.7%34.1%4.7%164.8%—

Related